Mitogen-activated protein kinase signaling pathway and invasion and metastasis of gastric cancer

World Journal of Gastroenterology

Volumn 21, Issue 41, 2015, Pages 11673-11679

  Yang, Mei ^a   Huang, Chang Zhi ^a  

^a CANCER HOSPITAL   (China)

Author keywords

Gastric cancer; Invasion; Metastasis; Mitogen activated protein kinase; Signaling

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN;

ARTICLE; CELL DEATH; CELL DIFFERENTIATION; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL STIMULATION; EARLY DIAGNOSIS; HUMAN; METASTASIS; NONHUMAN; OUTCOME ASSESSMENT; SIGNAL TRANSDUCTION; STOMACH CANCER; TUMOR INVASION; ANIMAL; CELL MOTION; ENZYMOLOGY; METABOLISM; PROGNOSIS; STOMACH TUMOR;

ANIMALS; CELL MOVEMENT; HUMANS; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASES; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; PROGNOSIS; STOMACH NEOPLASMS;

EID: 84947279768     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v21.i41.11673     Document Type: Article

References (59)

1. Plotnikov A, Zehorai E, Procaccia S, Seger R. The MAPK cascades: signaling components, nuclear roles and mechanisms of nuclear translocation. Biochim Biophys Acta 2011; 1813: 1619-1633 [PMID: 21167873 DOI: 10.1016/j.bbamcr.2010.12.012]
2. Yang SH, Sharrocks AD, Whitmarsh AJ. MAP kinase signalling cascades and transcriptional regulation. Gene 2013; 513: 1-13 [PMID: 23123731 DOI: 10.1016/j.gene.2012.10.033]
3. An JY, Pak KH, Inaba K , Cheong JH, Hyung WJ, Noh SH. Relevance of lymph node metastasis along the superior mesenteric vein in gastric cancer. Br J Surg 2011; 98: 667-672 [PMID: 21294111 DOI: 10.1002/bjs.7414]
4. Liu YF, Yang A , Liu W, Wang C, Wang M, Zhang L, Wang D, Dong JF, Li M. NME2 reduces proliferation, migration and invasion of gastric cancer cells to limit metastasis. PLoS One 2015; 10: e0115968 [PMID: 25700270 DOI: 10.137 1/journal. pone.0115968]
5. Guggenheim DE, Shah MA. Gastric cancer epidemiology and risk factors. J Surg Oncol 2013; 107: 230-236 [PMID: 23129495 DOI: 10.1002/jso.23262]
6. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011; 144: 646-674 [PMID: 21376230 DOI: 10.1016/j.cell.2011.02.013]
7. Fidler IJ. The pathogenesis of cancer metastasis: the ' seed and soil' hypothesis revisited. Nat Rev Cancer 2003; 3: 453-458 [PMID: 12778135 DOI: 10.1038/nrc1098]
8. Talmadge JE, Fidler IJ. AACR centennial series: the biology of cancer metastasis: historical perspective. Cancer Res 2010; 70: 5649-5669 [PMID: 20610625 DOI: 10.1158/0008-5472. CAN-10-1040]
9. Klein T, Bischoff R. Physiology and pathophysiology of matrix metalloproteases. Amino Acids 2011; 41: 271-290 [PMID: 20640864 DOI: 10.1007/s00726-010-0689-x]
10. Zhao J, Guan JL. Signal transduction by focal adhesion kinase in cancer. Cancer Metastasis Rev 2009; 28: 35-49 [PMID: 19169797 DOI: 10.1007/s10555-008-9165-4]
11. Gao X, Balan V, Tai G, Raz A. Galectin-3 induces cell migration via a calcium-sensitive MAPK/ERK1/2 pathway. Oncotarget 2014; Epub ahead of print [PMID: 24760816]
12. McFadden DG, Vernon A, Santiago PM, Martinez-McFaline R, Bhutkar A, Crowley DM, McMahon M, Sado w PM, Jacks T. p53 constrains progression to anaplastic thyroid carcinoma in a Braf-mutant mouse model of papillary thyroid cancer. Proc Natl Acad Sci USA 2014; 111: E1600-E1609 [PMID: 24711431 DOI: 10.1073/pnas.1404357111]
13. Wang H, An H, Wang B, Liao Q, Li W, Jin X, Cui S, Zhang Y, Ding Y, Zhao L. miR-133a represses tumour growth and metastasis in colorectal cancer by targeting LIM and SH3 protein 1 and inhibiting the MAPK pathway. Eur J Can cer 2013; 49: 3924-3935 [PMID: 23968734 DOI: 10.1016/j.ejca.2013.07.149]
14. Bollig F, Winzen R, Gaestel M, Kostka S, Resch K, Holtmann H. Affinity purification of ARE-binding p roteins identifies polyAbinding protein 1 as a potential substrate in MK2-induced mRNA stabilization. Biochem Biophys Res Commun 2003; 301: 665-670 [PMID: 12565831]
15. Bonni A, Brunet A, West AE, Datta SR, Takasu MA, Greenberg ME. Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and-independent mechanisms. Science 1999; 286: 1358-1362 [PMID: 10558990]
16. Cargnello M, Roux PP. Activation and function of the MAPKs and their substrates, the MAPK-Activated protein kinases. Microbiol Mol Biol Rev 2011; 75: 50-83 [PMID: 21372320 DOI: 10.1128/MMBR.00031-10]
17. Rapp UR, Götz R, Albert S. BuCy RAFs drive cells into MEK addiction. Cancer Cell 2006; 9: 9-12 [PMID: 16413467 DOI: 10.1016/j.ccr.2005.12.022]
18. Gan X, Huang S, Wu L , Wang Y, Hu G, Li G, Zhang H, Yu H, Swerdlow RH, Chen JX, Yan SS. Inhibition of ERK-DLP1 signaling and mitochondrial division alleviates mitochondrial dysfunction in Alzheimer's disease cybrid cell. Biochim Bioph ys Acta 2014; 1842: 220-231 [PMID: 24252614 DOI: 10.1016/j.bbadis.2013.11.009]
19. Ono Y, Tanaka H, Takata M, Nagahara Y, Noda Y, Tsuruma K, Shimazawa M, Hozumi I, Hara H. SA4503, a sigma-1 receptor agonist, suppresses motor neuron damage in in vitro and in vivo amyotrophic lateral sclerosis models. Neurosci Lett 2014; 559: 174-178 [PMID: 24334165 DOI: 10.1016/j.neulet.2013.12.005]
20. Kim EK, Choi EJ. Compromised MAPK signaling in human diseases: an update. Arch Toxicol 2015; 89: 867-882 [PMID: 25690731 DOI: 10.1007/s00204-015-1472-2]
21. Nho K , Ramanan VK, Horgusluoglu E, Kim S, Inlow MH, Risacher SL, McDonald BC, Farlow MR, Foroud TM, Gao S, Callahan CM, Hendrie HC, Niculescu AB, Saykin AJ. Comprehensive gene-And pathway-based analysis of depressive symptoms in older adults. J Alzheimers Dis 2015; 45: 1197-1206 [PMID: 25690665 DOI: 10.3233/JAD-148009]
22. Meng ZX, Wang L, Xiao Y, Lin JD. The Baf60c/Deptor pathway links skeletal muscle inflammation to glucose homeostasis in obesity. Diabetes 2014; 63: 1533-1545 [PMID: 24458360 DOI: 10.2337/db13-10 61]
23. Dhillon AS,Hagan S,Rath O,Kolch W. MAP kinase signalling pathways in cancer Oncogene 2007 26 3279-3290 PMID: 17496922 DOI: 10.1038/sj.onc.1210421]
24. Dav ies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S, Teague J, Woffendin H, Garnett MJ, Bottomley W, Davis N, Dicks E, Ewing R, Floyd Y, Gray K, Hall S, Hawes R, Hughes J, Kosmido u V, Menzies A, Mould C, Parker A, Stevens C, Watt S, Hooper S, Wilson R, Jayatilake H, Gusterson BA, Cooper C, Shipley J, Hargrave D, Pritchard-Jones K, Maitland N, Chenevix-Trench G, Riggin s GJ, Bigner DD, Palmieri G, Cossu A, Flanagan A, Nicholson A, Ho JW, Leung SY, Yuen ST, Weber BL, Seigler HF, Darrow TL, Paterson H, Marais R, Marshall CJ, Wooster R, Stratton MR, Futreal PA. Mutations of the BRAF gene in human cancer. Nature 2002; 417: 949-954 [PMID: 12068308 DOI: 10.1038/nature00766]
25. Xie H, Pallero MA, Gupta K, Chang P, Ware MF, Witke W, Kwia tkowski DJ, Lauffenburger DA, Murphy-Ullrich JE, Wells A. EGF receptor regulation of cell motility: EGF induces disassembly of focal adhesions independently of the motility-Associated PLCgamma signaling pathway. J Cell Sci 1998; 111 (Pt 5): 615-624 [PMID: 9454735]
26. Janda E, Lehmann K, Killisch I, Jechlinger M, Herzig M, Downward J, Beug H, Grünert S. Ras and TGF[beta] cooperatively regulate epithelial cell p lasticity and metastasis: dissection of Ras signaling pathways. J Cell Biol 2002; 156: 299-313 [PMID: 11790801 DOI: 10.1083/jcb.200109037]
27. Webb CP, Van Aelst L, Wigler MH, Vande Woude GF. Signaling pathways in Ras-mediated tumorigenicity and metastasis. ProcNatl Acad Sci USA 1998; 95: 8773-8778 [PMID: 9671754]
28. Yang GL, Tao HR, Wang HW, Sun Y, Zhang LD, Zhang C, He W, Xu MH, Zhao JM, Gao FH. Ara-C increases gastric cancer cell invasion by upregulating CD-147-MMP-2/MMP?9 via the ERK signaling pathway. Oncol Rep 2015; 33: 2045-2051 [PMID: 25625234 DOI: 10.3892/or.2015.3748]
29. Akter H, Park M, Kwon OS, Song EJ, Park WS, Kang MJ. Activation of matrix metalloproteinase-9 (MMP-9) by neurotensin promotes cell invasion and migration through ERK pathw ay in gastric cancer. Tumour Biol 2015; 36: 6053-6062 [PMID: 25724188 DOI: 10.1007/s13277-015-3282-9]
30. Yang M, Gu YY, Peng H, Zhao M, Wang J, Huang SK, Yuan XH, Li J, Sang JL, Luo Q, Huang C. NAIF1 inhibits gastric cancer cells migration and invasion via the MAPK pathways. J Cancer Res Clin Oncol 2015; 141: 1037-1047 [PMID: 25432142 DOI: 10.1007/s00432-014-1865-2]
31. Fukui H, Zhang X, Sun C, Hara K, Kikuchi S, Yamasaki T, Kondo T, Tomita T, Oshima T, Watari J, Imura J, Fujimori T, Sasako M, Miwa H. IL-22 produced by cancer-Associated fibr oblasts promotes gastric cancer cell invasion via STAT3 and ERK signaling. Br J Cancer 2014; 111: 763-771 [PMID: 24937671 DOI: 10.1038/bjc.2014.336]
32. Chen H, Cheng ZY, Pan Y, Wang Z, Liu Y, Zhang JQ. RASAL1 influences the proliferation and invasion of gastric cancer cells by regulating the RAS/ERK signaling pathway. Hum Cell 2014; 27: 103-110 [PMID: 24531877 DOI: 10.1007/s13577-014-0090-2]
33. Cao Y, Tu Y, Mei J, Li Z, Jie Z, Xu S, Xu L, Wang S, Xiong Y. RNAimediated knockdown of PRL?3 inhibits cell invasion and downregulates ERK 1/2 expression in the human gastric cancer cell line, SGC?7901. Mol Med Rep 2013; 7: 1805-1811 [PMID: 23589069 DOI: 10.3892/mmr.2013.1420]
34. Zhong J, Chen S, Xue M, Du Q, Cai J, Jin H, Si J, Wang L. ZIC1 modul ates cell-cycle distributions and cell migration through regulation of sonic hedgehog, PI(3)K and MAPK signaling pathways in gastric cancer. BMC Cancer 2012; 12: 290 [PMID: 22799764 DOI: 10.1186/1471-2407-12-290]
35. Zhong J, Zhao M, Luo Q, Ma Y, Liu J, Wang J, Yang M, Yuan X, Sang J, Huang C. CCDC134 is down-regulated in gastric cancer and its silencing promotes cell migration and invasion of GES-1 and AGS cells v ia the MAPK pathway. Mol Cell Biochem 2013; 372: 1-8 [PMID: 23070808 DOI: 10.1007/s11010-012-1418-4]
36. New L, Han J. The p38 MAP kinase pathway and its biological function. Trends Cardiovasc Med 1998; 8: 220-228 [PMID: 14987568]
37. Cuadrado A, Nebreda AR. Mechanisms and functions of p38 MAPK signalling. Biochem J 2010; 429: 403-417 [PMID: 20626350 DOI: 10.1042/BJ20100323]
38. Koul HK, Pal M, Koul S. Role of p38 MAP Kinase Signal Transduction in Solid Tumors. Genes Cancer 2013; 4: 342-359 [PMID: 24349632 DOI: 10.1177/1947601913507951]
39. Brancho D, Tanaka N, Jaeschke A, Ventura JJ, Kelkar N, Tanaka Y, Kyuuma M, Takeshita T, Flavell RA, Davis RJ. Mechanism of p38 MAP kinase activation in vivo . Genes Dev 2003; 17: 1969-1978 [PMID: 12893778 DOI: 10.1101/gad.1107303]
40. Bulavin DV, Fornace AJ. p38 MAP kinase's emerging role as a tumor suppressor. Adv Cancer Res 2004; 92: 95-118 [PMID: 15530558 DOI: 10.1016/S0065-230X(04)92005-2]
41. Iyoda K, Sasaki Y, Horimoto M, Toyama T, Yakushijin T, Sakakibara M, Takehara T, Fujimoto J, Hori M, Wands JR, Hayas hi N. Involvement of the p38 mitogen-Activated protein kinase cascade in hepatocellular carcinoma. Cancer 2003; 97: 3017-3026 [PMID: 12784337 DOI: 10.1002/cncr.11425]
42. Hong J, Zhou J, Fu J, He T, Qin J, Wang L, Liao L, Xu J. Phosphorylation of serine of Twist1 by MAPKs stabilizes Twist1 protein and promotes breast cancer cell invasiveness. Cancer Res 2011; 71: 3980-3990 [PMID: 21502402 DOI: 10.1158/0008-5472. CAN-10-2914]
43. Hipp S, Berg D, Ergin B, Schuster T, Hapfelmeier A, Walch A, Avril S, Schmalfeldt B, Höfler H, Becker KF. Interaction of Snail and p38 mitogen-Activated protein kinase results in shorter overall survival of ov arian cancer patients. Virchows Arch 2010; 457: 705-713 [PMID: 20957493 DOI: 10.1007/s00428-010-0986-5]
44. Radisky DC,Levy DD,Littlepage LE,Liu H,Nelson CM,Fata JE,Leake D,Godden EL,Albertson DG,Nieto MA,Werb Z,Bissell MJ. Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability Nature 2005 436 123-127 PMID: 16001073 DOI: 10.1038/nature03688]
45. Al-Mulla F, Bitar MS, Al-Maghrebi M, Behbehani AI, Al-Ali W, Rath O, Doyle B, Tan KY, Pitt A, Kolch W. Raf kinase inhibitor protein RKIP enhances signaling by glycogen synthase kinase-3?. Cancer Res 2011; 71: 1334-1343 [PMID: 21303975 DOI: 10.1158/0008-5472.CAN-10-3102]
46. Hsieh MJ, Chen KS, Chiou HL, Hsieh YS. Carbonic anhydrase XII promotes invasion and migration abil ity of MDA-MB-231 breast cancer cells through the p38 MAPK signaling pathway. Eur J Cell Biol 2010; 89: 598-606 [PMID: 20434230 DOI: 10.1016/j.ejcb.2010.03.004]
47. Johansson N, Ala-Aho R , Uitto V, Grénman R, Fusenig NE, López-Otín C, Kähäri VM. Expression of collagenase-3 (MMP-13) and collagenase-1 (MMP-1) by transformed keratinocytes is dependent on the activity of p38 mitogen-Activated protein kinase. J Cell Sci 2000; 113 Pt 2: 227-235 [PMID: 10633074]
48. Xu L, Chen S, Bergan RC. MAPKAPK2 and HSP27 are downstream effectors of p38 MAP kinase-mediated matrix metalloproteinase type 2 activation and cell invasion in human prostat e cancer. Oncogene 2006; 25: 2987-2998 [PMID: 16407830 DOI: 10.1038/sj.onc.1209337]
49. Kwon CH, Moon HJ, Park HJ, Choi JH, Park do Y. S100A8 and S100A9 promotes invasion and migration t hrough p38 mitogenactivated protein kinase-dependent NF-?B activation in gastric cancer cells. Mol Cells 2013; 35: 226-234 [PMID: 23456298 DOI: 10.1007/s10059-013-2269-x]
50. Yan X, Rui X, Zhang K. Baicalein inhibits the invasion of gastric cancer cells by suppressing the activity of the p38 signaling pathway. Oncol Rep 2015; 33: 737-743 [PMID: 25502212 DOI: 10.3892/or.2014.3669]
51. Dérijard B, Hibi M, Wu IH, Barrett T, Su B, Deng T, Karin M, Davis RJ. JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activat ion domain. Cell 1994; 76: 1025-1037 [PMID: 8137421]
52. Kyriakis JM, Banerjee P, Nikolakaki E, Dai T, Rubie EA, Ahmad MF, Avruch J, Woodgett JR. The stress-Activated protein kinase subfamily of c-Jun kinases. Nature 1994; 369: 156-160 [PMID: 8177321 DOI: 10.1038/369156a0]
53. Bode AM, Dong Z. The enigmatic effects of caffeine in cell cycle and cancer. Cancer Lett 2007; 247: 26-39 [PMID: 16709440 DOI: 10.1016/j.canlet.2006.03.032]
54. Bogoyevitch MA, Ngoei KR, Zhao TT, Yeap YY, Ng DC. c-Jun N-terminal kinase (JNK) signaling: recent advances and challenges. Biochim Biophys Acta 2010; 1804: 463-475 [PMID: 19900593 DOI: 10.1016/j.bbapap.2009.11.002]
55. J BH, M S, T D, R C, W BB, M O, H B, T B, M M, F K, A G, M H, T D, K R. [Retroperitoneal sarcomas: a single center experience]. Cancer Radiother 2008; 12: 331-335 [PMID: 18434228 DOI: 10.1016/j.canrad.2008.02.003]
56. Chen N, Nomura M, She QB, Ma WY, Bode AM, Wang L, Flavell RA, Dong Z. Suppression of skin tumorigenesis in c-Jun NH(2)-terminal kinase-2-deficient mice. Cancer Res 2001; 61: 3908-391 2 [PMID: 11358804]
57. She QB, Chen N, Bode AM, Flavell RA, Dong Z. Deficiency of c-Jun-NH(2)-terminal kinase-1 in mice enhances skin tumor development by 12-O-tetradecanoylphorbol-13-Acetate. Cancer Res 2002; 62: 1343-1348 [PMID: 11888903]
58. Jung MK, Houh YK, Ha S, Yang Y, Kim D, Kim TS, Yoon SR, Bang SI, Cho BJ, Lee WJ, Park H, Cho D. Recombinant Erdr1 suppress es the migration and invasion ability of human gastric cancer cells, SNU-216, through the JNK pathway. Immunol Lett 2013; 150: 145-151 [PMID: 23370368 DOI: 10.1016/j.imlet.2013.01.012]
59. Fu H, Hu Z, Wen J, Wang K, Liu Y. TGF-beta promotes invasion and metastasis of gastric cancer cells by increasing fascin1 expression via ERK and JNK signal pathways. Acta Biochim Biophys Sin (Shanghai) 2009; 41: 648-656 [ PMID: 19657566]